Elizabeth Connolly, MD (she/her/hers)

Research Fellow
Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia. Faculty of medicine and health, University of Sydney, Sydney, Australia., Australia

Liz is an early career medical oncologist, undertaking undertaking full time PhD research in sarcoma proteomics at ProCan, The ACRF International Centre for the Proteome of Human Cancer, and Chris O'Brien Lifehouse comprehensive cancer centre in Sydney, Australia.
Clinical research interests include further understanding of ultra-rare sarcoma subtypes, with an interst in CIC-rearranged sarcoma, and evaluating the feasibility of outpatient delivery of high dose methotrexate for AYA osteosarcoma (MYTH study). She is a member of the Australia New Zealand Sarcoma Association's (ANZSA) Sarcoma Guidelines update committee and ANZSA national database working group. She is a clinical lecturer with the University of Sydney and a member of the ESMO Young Oncologists Committee and MOGA Young Oncologists Committee.

Poster(s):

• (P 189) INTERNATIONAL RETROSPECTIVE STUDY FROM THE ULTRA-RARE SARCOMA WORKING GROUP ON LOW-GRADE FIBROMYXOID SARCOMA AND SCLEROSING EPITHELIOD FIBROSARCOMA: OUTCOME OF ADVANCED DISEASE AND SYSTEMIC THERAPIES